SCHEMBL2158567

SCHEMBL2158567

CN(C)CC(O)Cn1ccc(N)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HIF1A Q16665 2/20 0.33
MYLK Q15746 1/20 0.33
JAK2 O60674 2/20 0.32
JAK1 P23458 2/20 0.32
TYK2 P29597 2/20 0.32
JAK3 P52333 2/20 0.32
PDE10A Q9Y233 1/20 0.31
KCNH2 Q12809 1/20 0.31
MCHR1 Q99705 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2151487 1.00 DNM1 (0.43) DNM1SMN1; SMN2MAPTALDH1A1TDP1
SCHEMBL2360067 0.80 HIF1A (0.39) DNM1SMN1; SMN2MAPTALDH1A1TDP1
SCHEMBL2160162 0.80 HIF1A (0.39) DNM1SMN1; SMN2MAPTALDH1A1TDP1
SCHEMBL14556270 0.80 HIF1A (0.39) DNM1SMN1; SMN2MAPTALDH1A1TDP1
SCHEMBL1080403 0.80 ALDH1A1 (0.40) MAPTALDH1A1TDP1MEN1KMT2A
SCHEMBL1067071 0.80 ALDH1A1 (0.40) MAPTALDH1A1TDP1MEN1KMT2A
SCHEMBL1067067 0.80 ALDH1A1 (0.40) MAPTALDH1A1TDP1MEN1KMT2A
SCHEMBL3373849 0.79 DNM1 (0.39) DNM1SMN1; SMN2MAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL1082148 0.78 ALDH1A1 (0.39) MAPTALDH1A1TDP1MEN1KMT2A
SCHEMBL24884401 0.78 ALDH1A1 (0.42) ALDH1A1TDP1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2534132-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2017-04-26 EP disclosed
CN-102159207-B Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2015-02-04 CN disclosed
US-8354444-B2 Substituted pyrrolidine-2-carboxamides HOFFMANN-LA ROCHE INC. (US) 2013-01-15 US disclosed
EP-2340021-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2012-11-07 EP disclosed
CN-102753522-A Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2012-10-24 CN disclosed
CN-102159207-A Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2011-08-17 CN disclosed
EP-2340021-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES F. Hoffmann-La Roche AG (CH) 2011-07-06 EP disclosed
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides F. HOFFMANN-LA ROCHE AG (CH) 2010-06-17 US disclosed
WO-2010031713-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-03-25 WO disclosed
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides DING QINGJIE 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides ARG2, CCNY, PYCR1 DNM1 1021/4885SMN1; SMN2 2109/4885MAPT 4475/4885
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides ARG2, CCNY, PYCR1 DNM1 1021/4885SMN1; SMN2 2109/4885MAPT 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.